Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine...

Area of Science:

• Cardiology
• Molecular Biology
• Genetics

Background:

• Catecholaminergic polymorphic ventricular tachycardia (CPVT) is typically linked to gain-of-function mutations in cardiac ryanodine receptor (RyR2) channels, causing spontaneous calcium release.
• Loss-of-function mutations in RyR2 channels present an unexplained mechanism for CPVT-related arrhythmias.

Purpose of the Study:

• To investigate the arrhythmogenic mechanisms associated with a loss-of-function RyR2 mutation (RyR2-A4860G) in catecholaminergic polymorphic ventricular tachycardia (CPVT).

Main Methods:

• Recombinant RyR2-A4860G protein expression and activity assays ([(3)H]ryanodine binding, single channel recordings).
• Phenotypic analysis of RyR2-A4860G heterozygous mice, including basal heart rate and response to sympathetic stimulation.
• Electrophysiological studies on isolated ventricular myocytes from RyR2-A4860G mutant mice.

Main Results:

• RyR2-A4860G mutation significantly inhibited RyR2 channel activity.
• RyR2-A4860G heterozygous mice exhibited bradycardia and a lethal phenotype in homozygotes, with malignant arrhythmias upon sympathetic stimulation.
• In myocytes, the mutation led to reduced systolic calcium release, sarcoplasmic reticulum calcium overload, and triggered early afterdepolarizations via the Na(+)-Ca(2+) exchanger.

Conclusions:

• The RyR2-A4860G mutation causes CPVT through a novel mechanism involving sarcoplasmic reticulum calcium overload and subsequent activation of sarcolemmal currents.
• This study identifies new pathways for RyR2-mediated arrhythmogenesis, expanding the understanding of CPVT pathogenesis beyond gain-of-function mutations.